Dermatitis, Eczematous Recruiting Phase 2 Trials for Benralizumab (DB12023)

Also known as: Eczema / Eczematous dermatitis / Eczema NOS / Eczematous rash / Dermatitis eczematoid

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03563066Effect of Benralizumab in Atopic DermatitisTreatment